"Designing Growth Strategies is in our DNA"

U.S. Specialty Generics Market Size, Share & Industry Analysis, By Route of Administration (Injectable, Oral, and Others), By Indication (Cancer, Cardiovascular Diseases, Autoimmune Diseases, Infectious Diseases, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI109232

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, U.S., 2023
    2. Key Industry Developments, By Key Players
    3. New Product Launches, By Key Players
    4. Overview: Regulatory Framework for Specialty Generics, U.S.
    5. Impact of COVID-19 on the U.S. Specialty Generics Market
  5. U.S. Specialty Generics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Injectable
      2. Oral
      3. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Cancer
      2. Cardiovascular Diseases
      3. Autoimmune Diseases
      4. Infectious Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Hikma Pharmaceuticals PLC
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Mallinckrodt
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Amneal Pharmaceuticals LLC
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Viatris Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Endo Pharmaceuticals Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, U.S., 2023
    2. Key Industry Developments, By Key Players
    3. New Product Launches, By Key Players
    4. Overview: Regulatory Framework for Specialty Generics, U.S.
    5. Impact of COVID-19 on the U.S. Specialty Generics Market
  5. U.S. Specialty Generics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Injectable
      2. Oral
      3. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Cancer
      2. Cardiovascular Diseases
      3. Autoimmune Diseases
      4. Infectious Diseases
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Hikma Pharmaceuticals PLC
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Mallinckrodt
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Amneal Pharmaceuticals LLC
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Viatris Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Endo Pharmaceuticals Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: U.S. Specialty Generics Market Revenue Breakdown (USD Billion, %), By Route of Administration, 2023 & 2032

Figure 2: U.S. Specialty Generics Market Value Share (%), by Route of Administration, 2023 & 2032

Figure 3: U.S. Specialty Generics Market Value Share (%), by Indication, 2023 & 2032

Figure 4: U.S. Specialty Generics Market Value Share (%), by Distribution Channel, 2023 & 2032

Figure 5: U.S. Specialty Generics Market Share (%), By Company, 2023

Table 1: U.S. Specialty Generics Market Revenue (USD Billion) Forecast, by Route of Administration, 2019-2032

Table 2: U.S. Specialty Generics Market Revenue (USD Billion) Forecast, by Indication, 2019-2032

Table 3: U.S. Specialty Generics Market Revenue (USD Billion) Forecast, by Distribution Channel, 2019-2032

U.S. Specialty Generics Market
  • 2019-2032
  • 2023
  • 2019-2022
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports